Molecular Mechanisms Underlying the Effects of Statins in the Central Nervous System
3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, commonly referred to as statins, are widely used in the treatment of dyslipidaemia, in addition to providing primary and secondary prevention against cardiovascular disease and stroke. Statins’ effects on the central nervous system (CNS),...
Main Authors: | Amelia J. McFarland, Shailendra Anoopkumar-Dukie, Devinder S. Arora, Gary D. Grant, Catherine M. McDermott, Anthony V. Perkins, Andrew K. Davey |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2014-11-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/15/11/20607 |
Similar Items
-
Neuroprotective effects of statins against amyloid β-induced neurotoxicity
by: Hsin-Hua Li, et al.
Published: (2018-01-01) -
A Systematic Review of the Protective Actions of Cat’s Whiskers (Misai Kucing) on the Central Nervous System
by: Yin-Sir Chung, et al.
Published: (2020-05-01) -
Regenerative medicine for central nervous system disorders: Role of therapeutic molecules in stem cell therapy
by: Paola Suárez-Meade, et al.
Published: (2015-01-01) -
Long-Term Statin Administration Does Not Affect Warfarin Time in Therapeutic Range in Australia or Singapore
by: Nijole Bernaitis, et al.
Published: (2018-05-01) -
Statins Reduce Lipopolysaccharide-Induced Cytokine and Inflammatory Mediator Release in an In Vitro Model of Microglial-Like Cells
by: A. J. McFarland, et al.
Published: (2017-01-01)